Abstract
Non-alcoholic fatty liver disease (NAFLD) is a worldwide epidemic and may evolve in the long term, to steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma (HCC). There is an immediate need not only to better understand its pathogenesis, but also to develop an effective therapy to prevent progression to more severe forms, as well as, to evaluate methods that methods tha…